ES2176778T3 - Metodo de diagnostico para la aterosclerosis. - Google Patents

Metodo de diagnostico para la aterosclerosis.

Info

Publication number
ES2176778T3
ES2176778T3 ES97939604T ES97939604T ES2176778T3 ES 2176778 T3 ES2176778 T3 ES 2176778T3 ES 97939604 T ES97939604 T ES 97939604T ES 97939604 T ES97939604 T ES 97939604T ES 2176778 T3 ES2176778 T3 ES 2176778T3
Authority
ES
Spain
Prior art keywords
diagnostic method
aterosclerosis
level
hydroxyphenylacetaldehyde
atherosclerosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97939604T
Other languages
English (en)
Inventor
Jay W Heinecke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Application granted granted Critical
Publication of ES2176778T3 publication Critical patent/ES2176778T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBEN UN PROCEDIMIENTO DIAGNOSTICO Y UNA PRUEBA DE DETERMINACION DE LA ATEROSCLEROSIS Y ENFERMEDADES ANALOGAS QUE ESTAN RELACIONADAS CON LA ACTIVACION DE FAGOCITOS Y/O INFLAMACION, QUE COMPRENDE DETERMINAR LA PRESENCIA DE P - HIDROXIFENILACETALDEHIDO LISINA EN UNA MUESTRA DE ENSAYO DE UN FLUIDO O TEJIDO CORPORAL, A UN NIVEL ELEVADO CON RELACION AL NIVEL EXISTENTE EN UN PACIENTE NORMAL.
ES97939604T 1996-09-09 1997-09-03 Metodo de diagnostico para la aterosclerosis. Expired - Lifetime ES2176778T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/709,700 US5731208A (en) 1996-09-09 1996-09-09 Method of detecting conditions indicative of atherosclerosis

Publications (1)

Publication Number Publication Date
ES2176778T3 true ES2176778T3 (es) 2002-12-01

Family

ID=24850989

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97939604T Expired - Lifetime ES2176778T3 (es) 1996-09-09 1997-09-03 Metodo de diagnostico para la aterosclerosis.

Country Status (11)

Country Link
US (1) US5731208A (es)
EP (1) EP0931265B1 (es)
JP (1) JP3553612B2 (es)
AT (1) ATE217089T1 (es)
AU (1) AU4165297A (es)
CA (1) CA2264754C (es)
DE (1) DE69712352T2 (es)
DK (1) DK0931265T3 (es)
ES (1) ES2176778T3 (es)
PT (1) PT931265E (es)
WO (1) WO1998010295A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727102B1 (en) 1997-06-20 2004-04-27 Leuven Research & Development Vzw Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
US6133039A (en) * 1998-02-09 2000-10-17 Washinton University In vivo method for determination of oxidative stress
US6096556A (en) * 1998-02-09 2000-08-01 Washington University Method for the determination of oxidative stress
SE9802402D0 (sv) * 1998-07-03 1998-07-03 Karolinska Innovations Ab Method of diagnosing cardiovascular disease and early atherosclerosis
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
ATE343130T1 (de) * 1999-12-29 2006-11-15 Perkinelmer Life Sciences Inc Testtablett, kit und verfahren zum screening von körperflüssigkeiten von neugeborenen durch tandem-massenspektrometrie
DK1353666T3 (da) 2001-01-02 2013-10-14 Cleveland Clinic Foundation Myeloperoxidase, en risikoindikator for cardiovasculær sygdom
US7780950B2 (en) * 2002-01-02 2010-08-24 The Cleveland Clinic Foundation Systemic marker for monitoring anti-inflammatory and antioxidant actions of therapeutic agents
US6939716B2 (en) * 2001-09-19 2005-09-06 Washington University Method for detecting conditions indicative of sepsis
US7459286B1 (en) 2003-10-22 2008-12-02 The Cleveland Clinic Foundation Assessing the risk of a major adverse cardiac event in patients with chest pain
WO2005055810A2 (en) 2003-12-05 2005-06-23 The Cleveland Clinic Foundation Risk markers for cardiovascular disease
US20050181451A1 (en) * 2004-02-12 2005-08-18 Bates Harold M. Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants
US7378396B2 (en) 2004-08-11 2008-05-27 The Cleveland Clinic Foundation Therapeutic agents and methods for cardiovascular disease
US9744155B2 (en) 2012-03-28 2017-08-29 Ixcela, Inc. IPA as a therapeutic agent, as a protective agent, and as a biomarker of disease risk
US20150219621A1 (en) * 2014-01-31 2015-08-06 Counterpoint Health Solutions, Inc. Covalently bound metabolites as biomarkers
US11041847B1 (en) 2019-01-25 2021-06-22 Ixcela, Inc. Detection and modification of gut microbial population

Also Published As

Publication number Publication date
AU4165297A (en) 1998-03-26
EP0931265A1 (en) 1999-07-28
ATE217089T1 (de) 2002-05-15
JP3553612B2 (ja) 2004-08-11
DE69712352D1 (de) 2002-06-06
DE69712352T2 (de) 2002-11-14
DK0931265T3 (da) 2002-07-29
EP0931265B1 (en) 2002-05-02
WO1998010295A1 (en) 1998-03-12
CA2264754A1 (en) 1998-03-12
JP2001502792A (ja) 2001-02-27
CA2264754C (en) 2005-11-22
US5731208A (en) 1998-03-24
PT931265E (pt) 2002-09-30

Similar Documents

Publication Publication Date Title
ES2175453T3 (es) Procedimiento de diagnostico para la alterosclerosis.
ES2176778T3 (es) Metodo de diagnostico para la aterosclerosis.
DE69631738D1 (de) Medizinische implantierbare Vorrichtung für elektrochemische Messungen von Bluteigenschaften
DE69736527D1 (de) Messvorrichtung zur schnellen nichtinvasiven blutdruckbestimmung
NO971348D0 (no) Pröveenhet for oppsamling og undersökelse av kroppsvæske
DE69635174D1 (de) Nichtinvasive Vorrichtung zur Blutuntersuchung
DE69531743D1 (de) System und verfahren zur diagnose von krankheiten an lebendem gewebe
BR9814386B1 (pt) aparelhos e métodos para determinar a concentração de um componente medicamente significante de um fluido biológico.
ES2147555T3 (es) Ensayo de proteinas de la matriz nuclear en fluidos.
DE68918103D1 (de) Verfahren zur überwachung des kollagenabbaus.
DE69732223D1 (de) Ultraschall-Echographiesystem zur Untersuchung von Arterien
DE69601544T2 (de) Harnsammel und Untersuchungsvorrichtung, und Gebrauchsverfahren
EP0924523A3 (de) Verfahren und Diagnosemittel zum Nachweis von Hämostasestörungen
HU9202178D0 (en) Method for detecting irregularities of bone and other connective tissues in human beings and in animals
SE9401883L (sv) Sätt vid diagnosticering av födoämnesintolerans/allergi samt instrument för diagnostiseringen
ZA98665B (en) Method and apparatus for the measurement of blood coagulation properties with absorbent materials
ITMI950702A0 (it) Test diagnostico per il rilevamento rapido e sicuro di un marcatore clinico per la diagnosi di menopausa nella donna
EP0745221A4 (en) PYRIDINOLINE BRIDGES USEFUL FOR INDICATING THE SEVERITY OF PERIODONTIC OR PERIPHERAL CONDITIONS TO AN IMPLANT
FR2714812B1 (fr) Procédé de stérilisation d'instruments chirurgicaux et autoclave permettant de la mettre en Óoeuvre.
DE69522935T2 (de) Verfahren zur Erfassung der Geschwindigkeit von Gewebe oder Blut und Ultraschall-Diagnosevorrichtung
WO1994016103A3 (en) Detection of synthetic oligonucleotides extracted from body fluids or tissues
IT1276615B1 (it) Metodo per la rivelazione di catecolamine durante il ritmo circadiano, uso di detto metodo per la diagnosi e la terapia di malattie nervose
RU2000105525A (ru) Способ оценки степени тяжести интоксикации у детей с гнойно-септическими заболеваниями